Why the study?
Does long-term prognosis (all-cause mortality and HF hospitalization) differ among patients with reduced, mid-range, and preserved ejection fraction?
Does long-term prognosis (all-cause mortality and HF hospitalization) differ among patients with reduced, mid-range, and preserved ejection fraction?
Patients with HFmrEF have a more favorable long-term prognosis regarding mortality and heart failure hospitalizations compared to those with HFrEF or HFpEF.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: